CVS Health Co. (NYSE:CVS) Stock Holdings Lowered by Claro Advisors LLC

Claro Advisors LLC lowered its stake in CVS Health Co. (NYSE:CVS) by 70.7% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 2,773 shares of the pharmacy operator’s stock after selling 6,688 shares during the quarter. Claro Advisors LLC’s holdings in CVS Health were worth $174,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently bought and sold shares of CVS. Wellington Management Group LLP lifted its holdings in CVS Health by 33.2% in the 4th quarter. Wellington Management Group LLP now owns 219,030 shares of the pharmacy operator’s stock valued at $17,295,000 after acquiring an additional 54,616 shares during the last quarter. Park Avenue Securities LLC lifted its holdings in CVS Health by 3.2% in the 1st quarter. Park Avenue Securities LLC now owns 26,985 shares of the pharmacy operator’s stock valued at $2,152,000 after acquiring an additional 827 shares during the last quarter. &PARTNERS purchased a new stake in CVS Health during the first quarter valued at about $430,000. Steph & Co. boosted its holdings in shares of CVS Health by 192.0% in the first quarter. Steph & Co. now owns 438 shares of the pharmacy operator’s stock worth $35,000 after buying an additional 288 shares during the period. Finally, AdvisorNet Financial Inc boosted its holdings in shares of CVS Health by 30.6% in the first quarter. AdvisorNet Financial Inc now owns 7,005 shares of the pharmacy operator’s stock worth $559,000 after buying an additional 1,642 shares during the period. 80.66% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several research analysts have commented on the stock. Evercore ISI raised their target price on shares of CVS Health from $62.00 to $75.00 and gave the stock an “outperform” rating in a report on Tuesday, October 8th. Truist Financial raised their target price on shares of CVS Health from $66.00 to $76.00 and gave the stock a “buy” rating in a report on Friday, October 11th. Barclays upgraded shares of CVS Health from an “equal weight” rating to an “overweight” rating and raised their target price for the stock from $63.00 to $82.00 in a report on Thursday, October 10th. Wells Fargo & Company increased their price target on shares of CVS Health from $60.00 to $61.00 and gave the stock an “equal weight” rating in a research report on Monday, August 12th. Finally, Deutsche Bank Aktiengesellschaft reduced their price target on shares of CVS Health from $64.00 to $63.00 and set a “hold” rating for the company in a research report on Friday, August 9th. Nine research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $75.26.

CVS Health Trading Down 5.2 %

NYSE:CVS opened at $60.34 on Monday. CVS Health Co. has a 12 month low of $52.77 and a 12 month high of $83.25. The firm has a market cap of $75.75 billion, a price-to-earnings ratio of 10.60, a P/E/G ratio of 0.93 and a beta of 0.54. The company has a quick ratio of 0.66, a current ratio of 0.86 and a debt-to-equity ratio of 0.83. The company’s 50 day moving average is $59.80 and its 200-day moving average is $60.43.

CVS Health (NYSE:CVS) last released its quarterly earnings results on Wednesday, August 7th. The pharmacy operator reported $1.83 EPS for the quarter, beating analysts’ consensus estimates of $1.73 by $0.10. CVS Health had a net margin of 1.98% and a return on equity of 12.72%. The company had revenue of $91.23 billion for the quarter, compared to analyst estimates of $91.41 billion. During the same quarter last year, the firm posted $2.21 earnings per share. The company’s quarterly revenue was up 2.6% compared to the same quarter last year. Equities analysts anticipate that CVS Health Co. will post 6.51 EPS for the current year.

CVS Health Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, November 1st. Stockholders of record on Monday, October 21st will be given a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a dividend yield of 4.41%. The ex-dividend date of this dividend is Monday, October 21st. CVS Health’s dividend payout ratio is 46.75%.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.